ITGAM and glioma: Depletion of CD11b+ cells in gancyclovir treated CD11b-HSVTK mice exhibited improved survival and decreased tumor size [125], further demonstrating that the majority of tumor infiltrating CD11b+ cells represents a tumor-promoting population and subsequently that depletion of this population represents a potentially viable mechanism of promoting glioma rejection.